Multitargeted Modulation of Skin Dullness by HNHT Formulation: Synergistic Inhibition of Melanogenesis, Glycation, and Lipofuscin Deposition
Rattachement africain : us, cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Skin dullness, characterized by pigmentation disorders and yellowing, is a major cosmetic concern in Asian populations. Lipofuscin exhibits ultraviolet (UV)/visible light spectral absorption, reduces skin reflectance, and contributes to dullness, whereas existing therapies targeting melanogenesis and glycation lack comprehensive efficacy. This study aimed to evaluate the multimodal anti-dullness effects of a novel formulation (HNHT: hyaluronic acid, niacinamide, hydrolyzed red algae, and tranexamic acid). METHODS: In vitro models (melanocytes, keratinocytes, fibroblasts, ex vivo skin model, and three-dimensional (3D) skin models) were used to assess melanin regulation, glycation inhibition, and lipofuscin clearance. RESULTS: In ultraviolet B (UVB)-exposed 3D skin models, 12.5% HNHT significantly improved skin color, appearance, and brightness (8.44% increase in L* value) and reduced melanin content (12.5% inhibition). Then, 12.5% HNHT downregulated the expression of key melanogenic genes (TYR and MITF; p < 0.001) in melanocytes and decreased UVB-induced α-melanocyte-stimulating hormone secretion in keratinocytes (2867.78 versus 3444.72 pg/mL; p < 0.05). The formulation enhanced melanosome clearance through autophagy activation (174% LC3-II increase, 80% GP100 reduction; p < 0.01) and boosted antioxidant capacity via Nrf2 activation and reactive oxygen species reduction (p < 0.05). In glycation, 50% HNHT upregulated anti-glycation enzymes (GLO1, GLO2, and GPX1) and reduced carboxymethyllysine (CML) by 23.16% in fibroblasts (p < 0.01), while 100% HNHT decreased CML by 34.93% in ex vivo skin model. Furthermore, 50% HNHT suppressed hydrogen peroxide-induced lipofuscin accumulation by 52.20% (p < 0.01). CONCLUSIONS: These findings highlight HNHT as a multitargeted therapeutic agent that alleviates skin dullness through melanogenesis inhibition, enhances melanosome degradation, suppresses glycation, mitigates oxidative stress, and promotes lipofuscin clearance, thereby establishing a novel therapeutic paradigm against solar radiation-induced hyperpigmentation and skin yellowing.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.
- Titre Crossref
- Multitargeted Modulation of Skin Dullness by <scp>HNHT</scp> Formulation: Synergistic Inhibition of Melanogenesis, Glycation, and Lipofuscin Deposition
- Date Crossref
- 01/05/2026
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
B.E. Meyers & Co (United States) pays non établi dans la noticeEntreprise
-
Shandong Academy of Pharmaceutical Sciences pays non établi dans la noticeStructure de recherche
-
Shandong University pays non établi dans la noticeUniversité ou école supérieure
-
Ltd. Jinan China Meyer Bio‐Medicine Co. pays non établi dans la noticeEntreprise
-
Shandong Meimao Pharmaceutical Co. pays non établi dans la noticeOrganisation à but non lucratif
B.E. Meyers & Co (United States), Shandong Academy of Pharmaceutical Sciences et Shandong University, avec 2 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.